Long-Term Safety/Tolerability of Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumors (NETs) Patients With Carcinoid Syndrome (CS): The ELECT Long-Term Open-label Extension Vinik, A., Fisher, G., Kunz, P., Liyanage, N., Mirakhur, B., Lowenthal, S., Pommier, R., Shaheen, M., Wolin, E. LIPPINCOTT WILLIAMS & WILKINS. 2017: 437

View details for Web of Science ID 000394448600062